Post by Gubra

We are pleased to share that Gubra will be attending BioEquity Europe 2026 in Prague on May 4–6. Jacob Lange Moresco, Vice President of Business Development and Partnerships, will be there to connect with emerging biotechs, pharma, and investors and explore future partnership and in-licensing opportunities. With a strong track record in cardiometabolic diseases and deep expertise in peptide-based therapeutics, we are actively looking to expand across both therapeutic areas and modality platforms. Jacob invites you to reach out to him and connect via the partnering system. #BioEquityEurope #BIOEurope #Biotech #Pharma #BusinessDevelopment #Partnerships #Licensing #InLicensing #Cardiometabolic #PeptideTherapeutics